Copper-67 SAR-bisPSMA updates
Sydney, Australia 16 October 2024 Highlights Cohort 4 – SECuRE Trial The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of 67Cu-SAR-bisPSMA, following on from the announcement dated 12 September 20242. The patient is a 93-year-old with a…